Zdrowie i gospodarka · 04/03/2003
FDA Amends Biologics Regulations to Allow Exemptions from General Safety Test
The FDA is updating its biologics regulations to provide exemptions from the general safety test for certain biological products, allowing manufacturers to apply for exemptions if they demonstrate proper production controls and quality assurance safeguards.
Source: Federal Register — Food and Drug AdministrationOpen original release →